Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities

Immune checkpoint (IC) therapy provides substantial benefits to cancer patients but can also cause distinctive toxicities termed immune-related adverse events (irAEs). Biomarkers to predict toxicities will be necessary to improve management of patients receiving IC therapy. We relied on serological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Tahir, Salahaldin A., Gao, Jianjun, Miura, Yuji, Blando, Jorge, Tidwell, Rebecca S. S., Zhao, Hao, Subudhi, Sumit K., Tawbi, Hussein, Keung, Emily, Wargo, Jennifer, Allison, James P., Sharma, Padmanee
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2019
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825284/
https://ncbi.nlm.nih.gov/pubmed/31611368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1908079116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados